A specially designed drug prevented laboratory mice from developing heart failure after heart attacks, according to new ...
The following is a summary of “Comparative Outcomes of Left Main and Non-Left Main Percutaneous Coronary Intervention from ...
Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...
Use of smokeless tobacco, cigars, and pipes increased the risk for coronary heart disease and heart attacks, according to a ...
The video begins with a woman demonstrating to viewers the best way, in her opinion, to shovel snow. Lifting and scooping, ...
Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both ...
The myocardial infarction market is driven by the growing prevalence of cardiovascular diseases and advancements in diagnostics and treatments. Key factors include an aging population, ...
Medpage Today on MSN3d
GLP-1 Agents' Risks and Benefits Broader Than Previously ThoughtGLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...
Hudson Regional Hospital’s Cardiac Catheterization Lab has earned NJ State Department of Health approval for STEMI ...
The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback